Molecular Partners AG (MLLCF)

USD 4.22

(0.24%)

Long Term Debt Summary of Molecular Partners AG

  • Molecular Partners AG's latest annual long term debt in 2023 was 2.44 Million CHF , down -33.08% from previous year.
  • Molecular Partners AG's latest quarterly long term debt in 2024 Q2 was 1.83 Million CHF , down 0.0% from previous quarter.
  • Molecular Partners AG reported annual long term debt of 3.65 Million CHF in 2022, down -24.7% from previous year.
  • Molecular Partners AG reported annual long term debt of 4.85 Million CHF in 2021, down -19.69% from previous year.
  • Molecular Partners AG reported quarterly long term debt of 1.83 Million CHF for 2024 Q2, down 0.0% from previous quarter.
  • Molecular Partners AG reported quarterly long term debt of 2.74 Million CHF for 2023 Q3, down -9.9% from previous quarter.

Annual Long Term Debt Chart of Molecular Partners AG (2023 - 2013)

Historical Annual Long Term Debt of Molecular Partners AG (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 2.44 Million CHF -33.08%
2022 3.65 Million CHF -24.7%
2021 4.85 Million CHF -19.69%
2020 6.03 Million CHF 372.54%
2019 1.27 Million CHF 0.0%
2018 - CHF 0.0%
2017 - CHF 0.0%
2016 - CHF 0.0%
2015 - CHF 0.0%
2014 - CHF 0.0%
2013 - CHF 0.0%

Peer Long Term Debt Comparison of Molecular Partners AG

Name Long Term Debt Long Term Debt Difference
ContraFect Corporation 2.21 Million USD -10.588%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 88.311%
Intellipharmaceutics International Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -30450.0%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -39.221%
Propanc Biopharma, Inc. 58.64 Thousand USD -4067.661%
Marizyme, Inc. 667.12 Thousand USD -266.346%
Genus plc 228.2 Million USD 98.929%
Pharming Group N.V. 166.1 Million USD 98.529%
Therapeutic Solutions International, Inc. 5512.00 USD -44239.623%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -74.206%
IMV Inc. 27.39 Million USD 91.08%
AXIM Biotechnologies, Inc. 5.42 Million USD 54.962%
ONE Bio Corp. 592.19 Thousand USD -312.7%
RVL Pharmaceuticals plc 55.61 Million USD 95.605%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -98.964%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -340.686%
Oncotelic Therapeutics, Inc. 1.89 Million USD -28.735%
Skye Bioscience, Inc. 171.23 Thousand USD -1327.32%
GlobeStar Therapeutics Corporation - USD -Infinity%
Mesoblast Limited 100.29 Million USD 97.563%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -659.006%
MultiCell Technologies, Inc. 36.43 USD -6708656.519%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.978%
Arno Therapeutics, Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Halberd Corporation 150 Thousand USD -1529.333%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -1388.383%
argenx SE 15.35 Million USD 84.082%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD -9.793%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Bioxytran, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -54747.397%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -1835.045%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -965.894%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Genscript Biotech Corporation 287.12 Million USD 99.149%
Kadimastem Ltd 229.69 Thousand USD -964.038%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -9560.461%
Capstone Therapeutics Corp. 8.26 Million USD 70.426%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -229599.248%
Q BioMed Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1533.537%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 87.968%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -820.059%
NanoSphere Health Sciences Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -2955.0%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 68.747%
SYBLEU INC 300 Thousand USD -714.667%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1533.537%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -562.243%
Affymax, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 445 Thousand USD -449.213%
CytoDyn Inc. 141 Thousand USD -1633.333%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 70.012%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -434.792%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -110.508%
PureTech Health plc 18.25 Million USD 86.608%
Coeptis Therapeutics, Inc. 150 Thousand USD -1529.333%
IXICO plc 275 Thousand USD -788.727%
IntelGenx Technologies Corp. 11.83 Million USD 79.356%
Gelesis Holdings, Inc. 26.3 Million USD 90.71%
CSL Limited 11.23 Billion USD 99.978%
Cellectis S.A. 36.21 Million USD 93.251%